This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Decode Genetics Ehf. Active years: 2001-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chicago, IL (US) (2001 - 2009)
- Lake Barrington, IL (US) (2010 - 2012)
Company Filing History:
Years Active: 2001-2012
Title: The Innovative Contributions of Jeffrey R. Gulcher
Introduction
Jeffrey R. Gulcher, an accomplished inventor based in Lake Barrington, IL, has made significant strides in the fields of healthcare and genetics. With a total of five patents to his name, Gulcher's work focuses on innovative methods of diagnosing and preventing serious health conditions, particularly those related to myocardial infarction and associated disorders.
Latest Patents
Among Gulcher's latest patents are groundbreaking methodologies that diagnose susceptibility to myocardial infarction (MI) and screen for the LTA4H haplotype. His research sheds light on polymorphisms in the FLAP and LTA4H gene, which act as susceptibility markers for MI, acute coronary syndrome (ACS), stroke, and peripheral arterial occlusive disease (PAOD). The patented innovations detail pathway targeting for treatment and diagnostic applications to identify individuals at risk of these conditions. Notably, his invention includes methods for prophylactic therapy for MI in subjects of African ancestry, emphasizing the administration of therapeutic agents to inhibit leukotriene synthesis in vivo. Furthermore, he has developed compositions comprising leukotriene synthesis inhibitors and statins, aimed at decreasing C-reactive protein levels in individuals prone to MI, ACS, stroke, or PAOD.
Career Highlights
Gulcher currently contributes his expertise to Decode Genetics EHF, where he utilizes his extensive knowledge and experience in genetics and healthcare technology. His work has not only led to the development of vital diagnostic tools but has also opened the door for more personalized treatment strategies aimed at high-risk patients.
Collaborations
Throughout his career, Gulcher has collaborated with notable coworkers, including Mark E. Gurney and Anna Helgadottir. These partnerships have been instrumental in driving forward innovative solutions in the field of genetic research and healthcare.
Conclusion
Jeffrey R. Gulcher's inventive contributions are significant in the fight against cardiovascular diseases and other related ailments. His pioneering patents reveal a deep commitment to improving patient outcomes through innovative diagnostics and treatment options. As advancements in medical technology continue to evolve, Gulcher’s work promises to lead the way in personalized medicine and healthcare strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile